| Dale F Andres, DO | |
|
1111 6th Ave, Mercy Medical Center Pathology Dept, Des Moines, IA 50314-2610 | |
| (515) 247-3115 | |
| Not Available |
| Full Name | Dale F Andres |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1111 6th Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841221710 | NPI | - | NPPES |
| 39050 | Other | IA | BC/BS |
| 1303370 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 01555 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dale F Andres, DO 2231 Nw 108th St, Des Moines, IA 50325-3729 Ph: (515) 334-7524 | Dale F Andres, DO 1111 6th Ave, Mercy Medical Center Pathology Dept, Des Moines, IA 50314-2610 Ph: (515) 247-3115 |
News Archive
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth.
We all know the adage: A little bit of a good thing can go a long way. Now researchers in London are reporting that might also be true for a large protein associated with wound healing.
Heavy backpacks place a measurable strain on the spines of children, with heavier loads causing greater spinal strain and increased back pain, reports a study in the January 1 issue of Spine.
NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.S. Food and Drug Administration has accepted and filed for review the company's Biologics License Application for Natpara (recombinant human parathyroid hormone 1-84, (rhPTH[1-84])) for the treatment of hypoparathyroidism.
› Verified 1 days ago
Ramona Ann Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-8638 | |
Dr. Carolyn Su-ying Pease, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Avenue, Mercy Medical Center, Des Moines, IA 50314 Phone: 515-643-8533 Fax: 515-643-8911 | |
Dr. Lorie A. Montag, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant, Suite #ll3, Des Moines, IA 50309 Phone: 515-241-8861 Fax: 515-241-8855 | |
Timothy Floyd Drevyanko, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 | |
Jacob Edward Sramek, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Suite Ll3, Des Moines, IA 50309 Phone: 515-241-8866 | |
Edward Fredric Loeb, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 | |
Richard Kent Scupham, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 |